83M-18220-88593
3 vaccinations
2 coded responses
37 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 853 / AZ
- Registered
- 2021-08-09
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- N/A
Registered dependents
6PC-29397-81996
Child or adolescent in my care · Female · 2022-07-05
Timeline
-
2021-08-09
Registered in v-safe
-
2021-08-09
Dose 1 — Pfizer-BioNTech
- 2021-08-09
-
2021-08-10
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Fatigue or tirednessAdult check-in
-
2021-08-11
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Redness, Swelling, Itching · Headache, DiarrheaAdult check-in
- 2021-08-12
- 2021-08-13
- 2021-08-14
- 2021-08-15
- 2021-08-16
- 2021-08-25
-
2021-08-30
Dose 2 — Pfizer-BioNTech
- 2021-08-30
-
2021-08-31
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · HeadacheAdult check-in
-
2021-09-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · HeadacheAdult check-in
-
2021-09-02
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Redness, Itching · NoneAdult check-in
-
2021-09-04
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Redness, Swelling, Itching · Fever · Headache, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-09-05
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Redness · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
-
2021-09-06
Health check-in — day 7, dose 2Feeling: Fair · Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesAdult check-in
- 2021-09-13
-
2021-09-20
Survey response — day 21, dose 2MedDRA: Rash — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Still having a bad rash on my legs started 3 days after 2nd doseMedDRA releases: 2024-11 · check-in free text available
- 2021-09-27
- 2021-10-04
- 2021-10-11
- 2021-11-29
-
2022-02-16
Dose 3 — Pfizer-BioNTech
- 2022-02-16
-
2022-02-17
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling, Itching · Fatigue or tirednessAdult check-in
- 2022-02-18
-
2022-02-19
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: ItchingFree text: Swollen neck lymp nodesMedDRA releases: 2024-11 · check-in free text available
- 2022-02-21
-
2022-02-22
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Itching · Fatigue or tirednessAdult check-in
- 2022-02-23
- 2022-03-02
- 2022-03-11
- 2022-03-16
- 2022-03-23
- 2022-03-30
- 2022-05-18
- 2022-08-17
- 2023-02-16
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-09 | Pfizer-BioNTech | No |
| 2 | 2021-08-30 | Pfizer-BioNTech | No |
| 3 | 2022-02-16 | Pfizer-BioNTech | No |
Free text
Release 9 — day 21, dose 2
Symptoms: Still having a bad rash on my legs started 3 days after 2nd dose
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen neck lymp nodes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Rash | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release